Select an indication for CABOMETYX® (cabozantinib)
CABOMETYX® is a small molecule that inhibits multiple receptor tyrosine kinases implicated in tumour growth and angiogenesis, pathologic bone remodelling, drug resistance and metastatic progression of cancer.1
You are about to leave Cabometyx Norway. This link is provided as a service to our website visitors. It will take you to a website maintained by a third party who is solely responsible for its content. Ipsen does not control, recommend, endorse or accept liability for sites controlled by third parties.
You are about to leave Cabometyx.no. This link is provided as a service to our website visitors. It will take you to another website maintained by Ipsen.